Prevention of perinatal group B streptococcal disease in Canada: An update

Area of Science:

• Obstetrics and Gynecology
• Neonatal Medicine
• Infectious Disease Prevention

Background:

• Group B streptococcal (GBS) infection poses a risk to newborns.
• Previous guidelines for GBS prevention have been in place since 1994.
• Updated recommendations are crucial for improving infant health outcomes.

Purpose of the Study:

• To summarize the revised Centers for Disease Control and Prevention (CDC) guidelines for preventing early-onset GBS infection.
• To compare and contrast the new CDC guidelines with the 1994 Canadian consensus guidelines.
• To inform healthcare providers about updated GBS prevention strategies.

Main Methods:

• Review and summary of the recently issued CDC guidelines.
• Comparative analysis of the new guidelines against existing Canadian consensus guidelines.
• Identification of key recommendations for intrapartum antibiotic prophylaxis.

Main Results:

• The CDC recommends two primary strategies for GBS prevention.
• Strategy 1: Offer intrapartum antibiotic prophylaxis to GBS carriers identified via prenatal screening (35-37 weeks gestation) and to women with premature labor or membrane rupture (<37 weeks gestation).
• Strategy 2: Offer intrapartum prophylaxis to women with risk factors present at labor onset or membrane rupture.

Conclusions:

• The revised CDC guidelines provide updated recommendations for GBS prevention.
• These guidelines offer flexibility through two distinct prevention strategies.
• Adherence to updated guidelines is expected to enhance the prevention of early-onset GBS infection.